OBJECTIVE: This study aimed to assess quantitative human papillomavirus (HPV) type 16 and HPV18 detection in oral rinses obtained in dental offices in Seattle, Washington. METHODS: We evaluated oral rinses collected during dental visits from 2016 to 2018. Multiplex TaqMan quantitative polymerase chain reaction was used to determine HPV16 and HPV18 viral load (VL). RESULTS: Of 15,313 persons, 152 (1%) had detectable oral HPV16/18. Men were at higher risk of oral HPV16/18 infection than women (1.6% vs. 0.6%; odds ratio, 3.2; 95% confidence interval, 2.1-4.4). Compared with women, men with HPV16 were older (median, 55 vs. 48 years; P < 0.001) and had higher VL (39.7 vs. 1.1 copies/mL, P < 0.001). Of 39 with HPV16 at baseline and a second oral rinse, 13 remained positive at subsequent rinse; of 8 with HPV18 at baseline, 2 remained positive at subsequent rinse. Persons with consecutive positive test results were all men and had higher baseline VL compared with those with first positive and second negative samples. CONCLUSION: Oral rinse is an acceptable method of HPV testing, and persons are interested in testing. Overall HPV16/18 prevalence was low, and detection was more frequent among men than women, especially at higher copy numbers. HPV16 persistence was more common in men with high VL at baseline test. Future studies are needed to evaluate the feasibility of an effective secondary prevention strategy for oropharyngeal cancer using quantitative oral HPV detection.
OBJECTIVE: This study aimed to assess quantitative human papillomavirus (HPV) type 16 and HPV18 detection in oral rinses obtained in dental offices in Seattle, Washington. METHODS: We evaluated oral rinses collected during dental visits from 2016 to 2018. Multiplex TaqMan quantitative polymerase chain reaction was used to determine HPV16 and HPV18 viral load (VL). RESULTS: Of 15,313 persons, 152 (1%) had detectable oral HPV16/18. Men were at higher risk of oral HPV16/18infection than women (1.6% vs. 0.6%; odds ratio, 3.2; 95% confidence interval, 2.1-4.4). Compared with women, men with HPV16 were older (median, 55 vs. 48 years; P < 0.001) and had higher VL (39.7 vs. 1.1 copies/mL, P < 0.001). Of 39 with HPV16 at baseline and a second oral rinse, 13 remained positive at subsequent rinse; of 8 with HPV18 at baseline, 2 remained positive at subsequent rinse. Persons with consecutive positive test results were all men and had higher baseline VL compared with those with first positive and second negative samples. CONCLUSION: Oral rinse is an acceptable method of HPV testing, and persons are interested in testing. Overall HPV16/18 prevalence was low, and detection was more frequent among men than women, especially at higher copy numbers. HPV16 persistence was more common in men with high VL at baseline test. Future studies are needed to evaluate the feasibility of an effective secondary prevention strategy for oropharyngeal cancer using quantitative oral HPV detection.
Authors: D Brad Rindal; Gregg H Gilbert; Claudia Carcelén; Ellen Funkhouser; Emily Durand; David A Uppgaard; Jeff Fellows; Jana Ikeda; Alexander Ross Kerr; Branden Brar; Valeria V Gordan; Sudhir Agarwal; Peter Barnett; Robert K Pickard; Maura Gillison Journal: J Am Dent Assoc Date: 2019-02 Impact factor: 3.634
Authors: Melina J Windon; Tim Waterboer; Alexander T Hillel; Wade Chien; Simon Best; Charles Stewart; Lee Akst; Tanya Troy; Noemi Bender; Brett Miles; William R Ryan; Rajarsi Mandal; Karen Pitman; David W Eisele; Carole Fakhry; Gypsyamber D'Souza Journal: Hum Vaccin Immunother Date: 2019-03-19 Impact factor: 3.452
Authors: Aimée R Kreimer; Christine M Pierce Campbell; Hui-Yi Lin; William Fulp; Mary R Papenfuss; Martha Abrahamsen; Allan Hildesheim; Luisa L Villa; Jorge J Salmerón; Eduardo Lazcano-Ponce; Anna R Giuliano Journal: Lancet Date: 2013-07-02 Impact factor: 79.321
Authors: Samantha Tam; Shuangshuang Fu; Li Xu; Kate J Krause; David R Lairson; Hongyu Miao; Erich M Sturgis; Kristina R Dahlstrom Journal: Oral Oncol Date: 2018-05-21 Impact factor: 5.337
Authors: Eleni M Rettig; Alicia Wentz; Marshall R Posner; Neil D Gross; Robert I Haddad; Maura L Gillison; Carole Fakhry; Harry Quon; Andrew G Sikora; William J Stott; Jochen H Lorch; Christine G Gourin; Yingshi Guo; Weihong Xiao; Brett A Miles; Jeremy D Richmon; Peter E Andersen; Krzysztof J Misiukiewicz; Christine H Chung; Jennifer E Gerber; Shirani D Rajan; Gypsyamber D'Souza Journal: JAMA Oncol Date: 2015-10 Impact factor: 31.777
Authors: Tsung-chieh Jane Fu; James P Hughes; Qinghua Feng; Ayaka Hulbert; Stephen E Hawes; Long Fu Xi; Stephen M Schwartz; Joshua E Stern; Laura A Koutsky; Rachel L Winer Journal: Sex Transm Dis Date: 2015-12 Impact factor: 2.830
Authors: Anil K Chaturvedi; Barry I Graubard; Tatevik Broutian; Weihong Xiao; Robert K L Pickard; Lisa Kahle; Maura L Gillison Journal: JAMA Date: 2019-09-10 Impact factor: 56.272
Authors: Ilir Agalliu; Susan Gapstur; Zigui Chen; Tao Wang; Rebecca L Anderson; Lauren Teras; Aimée R Kreimer; Richard B Hayes; Neal D Freedman; Robert D Burk Journal: JAMA Oncol Date: 2016-05-01 Impact factor: 31.777